what is microdosing for glp 1 GLP-1s: Risks & Considerations Should Everyone be Microdosing GLP-1s?

2 BPC/TB500 Description: A combination of peptides BPC-157 and TB500 (Thymosin Beta-4)

IGF-1 LR3 was developed as a more potent version of insulin-like growth hormone-1, as it has better stability and efficiency for stimulating cell growth during in vitro experiments

At 24 h post-treated, cell viability was determined and 30% inhibitory concentration (IC 30 ) of AFB 1 was calculated

This pairing is widely studied for its ability to mimic the bodys natural pulsatile GH secretion, producing synergistic and physiologically balanced effects on growth hormone and IGF-1 output without significant influence on cortisol or prolactin levels